BA
Bhavana Agrawal
About Bhavana Agrawal
Data last updated:
Bhavana Agrawal is a Whole-Time Director at Astrazeneca Pharma India Limited (since 2024). The company operates in Pharma. Astrazeneca Pharma India Limited reported revenue of ₹1,757 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Astrazeneca Pharma India Limited L24231KA1979PLC003563 | Whole-Time Director | 08 Feb 2024 | 1979 | ₹1,757 Cr (FY 2025) | Active |
Board colleagues of Bhavana Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashok Revathy | 00057539 | Astrazeneca Pharma India Limited | Director |
| Hooi Bien Chuah | 10381891 | Astrazeneca Pharma India Limited | Director |
| Monica | 07674403 | Astrazeneca Pharma India Limited | Director |
| Praveen Rao Akkinepally | 11137771 | Astrazeneca Pharma India Limited | Managing Director |
| Shilpa Divekar Nirula | 06619353 | Astrazeneca Pharma India Limited | Director |
| Tanya Sanish | Astrazeneca Pharma India Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavana Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavana Agrawal
Bhavana Agrawal currently holds 1 directorship: Astrazeneca Pharma India Limited (Whole-Time Director, since 08 Feb 2024, revenue ₹1,757 Cr (FY 2025)).
Bhavana Agrawal was first appointed on 08 Feb 2024 as Whole-Time Director at Astrazeneca Pharma India Limited.
The current boards of Bhavana Agrawal's companies include Ashok Revathy (Astrazeneca Pharma India Limited), Hooi Bien Chuah (Astrazeneca Pharma India Limited), Monica (Astrazeneca Pharma India Limited), Praveen Rao Akkinepally (Astrazeneca Pharma India Limited), Shilpa Divekar Nirula (Astrazeneca Pharma India Limited), Tanya Sanish (Astrazeneca Pharma India Limited).